Procter & Gamble Co. buy BNP Paribas Exane
Start price
27.09.25
/
50%
€130.46
Target price
27.09.26
€146.97
Performance (%)
-4.51%
Price
16.01.26
€124.58
Summary
This prediction is currently active. With a performance of -4.51%, the BUY prediction by BNP_Paribas_Exane is trending in the wrong direction. This prediction currently runs until 27.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Procter & Gamble Co. | 2.182% | 2.182% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Procter & Gamble Co. diskutieren
Procter & Gamble (NYSE:PG) had its price target lowered by analysts at BNP Paribas Exane from $177.00 to $172.00. They now have an "outperform" rating on the stock.
Ratings data for PG provided by MarketBeat

